November 28th 2017EP. 1: Understanding Ovarian Cancer
November 28th 2017EP. 2: Expertise on the Ovarian Cancer Healthcare Team
November 28th 2017EP. 3: Role of PARP Inhibition in Ovarian Cancer
November 28th 2017EP. 4: Delaying Recurrence in Ovarian Cancer
November 28th 2017EP. 5: Efficacy and Safety of Olaparib and Niraparib in Switch Maintenance
November 28th 2017EP. 6: Efficacy and Safety of Rucaparib: A Focus on ARIEL3
November 28th 2017EP. 7: Ovarian Cancer: Practical Considerations in Maintenance
November 28th 2017EP. 8: Predictive Markers in Ovarian Cancer
November 28th 2017EP. 9: Patient Selection and PARP Inhibitors in Ovarian Cancer
November 28th 2017EP. 10: Management Challenges in Ovarian Cancer
November 28th 2017EP. 11: Guidance for Payer Decisions in Ovarian Cancer
November 28th 2017EP. 12: Consulting With Gynecologic Oncologists for Input
November 28th 2017EP. 13: Ovarian Cancer: Coverage of PARP Inhibitors
